$20M Fund For Connecting Early-Stage Israeli Startups To New York City
97212 Ventures is focused on pre-seed and seed investing in Israeli startups, facilitating their entry into the U.S. market.
Stay updated with breaking news from Belkin Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
97212 Ventures is focused on pre-seed and seed investing in Israeli startups, facilitating their entry into the U.S. market.
Belkin Vision has developed an efficient, non-contact, and automated glaucoma laser therapy accessible to all ophthalmologists.
The Swiss-American ophthalmology company will pay $60 million immediately and up to $335 million with milestone payments for the company, BioLight reports.
/PRNewswire/ - [BELKIN Vision], an innovator in ophthalmic medical solutions, is pleased to announce that the U.S. Food and Drug Administration (FDA) has...
The Direct SLT, invented by Belkin Vision, automates the laser treatment that's currently available